Clinical TrialPlasma Galectin-3 and Heart Failure Outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)
Under a Creative Commons license
open access
Key Words
Prognosis
cardiac resynchronization therapy
biomarkers
patient selection
Cited by (0)
Funding: Boston Scientific Corporation and BG Medicine.
See page 798 for disclosure information.
Copyright © 2014 The Authors. Published by Elsevier Inc.